HOLLY SPRINGS,919 Marketing has signed on two new clients as it expands its representation of life science companies, Ajinomoto Aminoscience and Oriel Therapeutics.
Ajinomoto is the Raleigh-based division of a Japanese firm and is focused on amino acids.
Oriel Therapeutics is focused on dry power inhalers.
“Oriel Therapeutics and Ajinomoto are very different companies — Oriel is an early stage company with truly breakthrough inhalation technology, while Ajinomoto Aminoscience is a dominant global leader in the amino acid space,” said David Chapman, chief executive officer and founder of 919 Marketing, in a statement. “However, client companies of all sizes recognize the business impact of breakthrough marketing and public relations programs can have on company growth and market expansion.”
919 Marketing: www.919marketing.com
